Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0304978 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2024. Verfasst von Ariel Bardach und 9 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina. Hauptthemen laut MEDLINE: Pneumococcal Infections, Pneumococcal Vaccines, Serogroup, Streptococcus pneumoniae. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Abstract (Originalsprache)
Background
Invasive pneumococcal diseases (IPD) are associated with high morbidity, mortality, and health costs worldwide, particularly in Latin America and the Caribbean (LAC). Surveillance about the distribution of serotypes causing IPD and the impact of pneumococcal vaccination is an important epidemiological tool to monitor disease activity trends, inform public health decision-making, and implement relevant prevention and control measures.
Objectives
To estimate the serotype distribution for IPD and the related disease burden in LAC before, during, and after implementing the pneumococcal vaccine immunization program in LAC.
Methods
Systematic literature review following Cochrane methods of studies from LAC. We evaluated the impact of the pneumococcal vaccine on hospitalization and death during or after hospitalizations due to pneumococcal disease and serotype-specific disease over time. We also analyzed the incidence of serotyped IPD in pneumococcal conjugate vaccine PCV10 and PCV13. The protocol was registered in PROSPERO (ID: CRD42023392097).
Results
155 epidemiological studies were screened and provided epidemiological data on IPD. Meta-analysis of invasive diseases in children
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.
- Centro de Investigaciones Epidemiológicas y Salud Pública (CIESP-IECS), CONICET, Buenos Aires, Argentina.
- Departamento de Investigación, Hospital Garrahan, Buenos Aires, Argentina.
- Departamento de Evaluación de Tecnologías Sanitarias y Economía de la Salud, Instituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.
- Unidad de Pediatría, Hospital General de Agudos Vélez Sarsfield, Buenos Aires, Argentina.
- Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS ''Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
ORCID-Profile: Ariel Bardach
Förderung
- Pfizer
Zitieren
APA
Bardach, A., Ruvinsky, S., Palermo, M. C., Alconada, T., Sandoval, M. M., Brizuela, M. E., Wierzbicki, E. R., Cantos, J., Gagetti, P., & Ciapponi, A. (2024). Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0304978
Vancouver
Bardach A, Ruvinsky S, Palermo MC, Alconada T, Sandoval MM, Brizuela ME, et al. Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0304978
BibTeX
@article{Bardach2024,
author = {Bardach, Ariel and Ruvinsky, Silvina and Palermo, M Carolina and Alconada, Tomás and Sandoval, M Macarena and Brizuela, Martín E and Wierzbicki, Eugenia Ramirez and Cantos, Joaquín and Gagetti, Paula and Ciapponi, Agustín},
title = {Invasive pneumococcal disease in Latin America and the Caribbean: Serotype distribution, disease burden, and impact of vaccination. A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0304978}
}
EUVIMED